1. Home
  2. MSAI vs GBIO Comparison

MSAI vs GBIO Comparison

Compare MSAI & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Infrared Cameras Holdings Inc.

MSAI

Infrared Cameras Holdings Inc.

HOLD

Current Price

$0.50

Market Cap

25.9M

Sector

N/A

ML Signal

HOLD

Logo Generation Bio Co.

GBIO

Generation Bio Co.

HOLD

Current Price

$5.47

Market Cap

35.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MSAI
GBIO
Founded
1995
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.9M
35.4M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
MSAI
GBIO
Price
$0.50
$5.47
Analyst Decision
Strong Buy
Buy
Analyst Count
2
4
Target Price
$2.75
$10.67
AVG Volume (30 Days)
2.1M
39.5K
Earning Date
11-13-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,563,000.00
$15,270,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$106.56
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.46
$3.00
52 Week High
$3.33
$13.00

Technical Indicators

Market Signals
Indicator
MSAI
GBIO
Relative Strength Index (RSI) 37.85 51.71
Support Level $0.53 $5.22
Resistance Level $0.64 $5.64
Average True Range (ATR) 0.06 0.25
MACD -0.01 0.05
Stochastic Oscillator 3.35 67.19

Price Performance

Historical Comparison
MSAI
GBIO

About MSAI Infrared Cameras Holdings Inc.

MultiSensor AI Holdings Inc build and deploy intelligent multi-sensing platforms incorporating edge and cloud software solutions that leverage artificial intelligence (AI). It is a provider of sensing systems built around high-resolution thermal imagers, visible and acoustic imagers, as well as vibration and laser spectroscopy sensors, that perceive and measure heat, sound, vibration, and gas in industrial assets and the surrounding environment, helping companies gain insight to protect and manage their most important assets and infrastructure. It also offers a wide range of form factors for its sensor devices, including, among other form factors, small to large handheld designs with built-in displays and controls, and fixed-mounted single- and multi-sensor camera sensor systems.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: